ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
Obstructive sleep apnoea (OSA), atrial fibrillation (AF) and sudden cardiac death (SCD) may occur concomitantly, and are of considerable epidemiological interest, potentially leading to morbidity and mortality. Effective treatment of OSA with continuous positive airway pressure (CPAP) could prevent...
Main Authors: | Schlatzer, C, Bratton, D, Craig, S, Kohler, M, Stradling, J |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
BMJ Publishing Group
2016
|
פריטים דומים
-
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
מאת: Craig, SE, et al.
יצא לאור: (2012) -
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
מאת: Craig, SE, et al.
יצא לאור: (2012) -
Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea.
מאת: Schulz, U, et al.
יצא לאור: (2013) -
Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.
מאת: Bratton, D, et al.
יצא לאור: (2014) -
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea.
מאת: Ayers, L, et al.
יצא לאור: (2009)